Jesup & Lamont Announces Presenting LifeTech Companies and Former FDA Commissioner...

Jesup & Lamont Announces Presenting LifeTech Companies and Former FDA
Commissioner at Annual Growth Stock & National Sales Conference

NEW YORK, July 13 /PRNewswire-FirstCall/ -- Jesup & Lamont, Inc., (Amex: JLI),
a full-service boutique brokerage and investment banking firm serving retail
and institutional clients, today announced the LifeTech Capital Group
companies presenting at its 2009 Growth Stock & National Sales Conference to
be held at the Waldorf Astoria Boca Beach Club on July 30th, 2009 in Boca
Raton, Florida. In addition, former FDA Commissioner Dr. Lester M. Crawford
D.V.M., Ph.D., will be the keynote speaker for the event.

"As large pharmaceutical companies continue to struggle with patent
expirations, pricing pressures, R&D cuts and changes to the U.S. healthcare
system, we believe smaller biotech companies represent an exciting source of
value-creation for investors," says Stephen M. Dunn, Managing Director of Life
Sciences Research at LifeTech Capital Group. "With the government's recent
demands for comparative effectiveness of drugs, there is a corresponding
increase in demand for companies with novel, breakthrough approaches. We're
pleased to have such a diversified group of innovative biotech companies
presenting at our conference."

Some of the companies presenting on July 30th include Peregrine
Pharmaceuticals (Nasdaq: PPHM), Cytori Therapeutics (Nasdaq: CYTX), NovaBay
Pharmaceuticals (Amex: NBY), Nabi Biopharmaceuticals (Nasdaq: NABI), OXiGENE
Inc. (Nasdaq: OXGN), Access Pharmaceuticals (OTC Bulletin Board: ACCP), Echo
Therapeutics (OTC Bulletin Board: ECTE), Raptor Pharmaceuticals (OTC Bulletin
Board: RPTP), Neoprobe Corp. (OTC Bulletin Board: NEOP) and Oxygen
Biotherapeutics (OTC Bulletin Board: OXBO).

Jesup's annual conference provides its clients a distinctive forum in which to
visit with and hear presentations from unique growth companies in the life
sciences, healthcare, aerospace and transportation industries. The conference
commences with Life Science industry and investor panels on Wednesday July
29th with Company presentations on Thursday July 30th, followed by Investment
Products presentations on August 1st and 2nd. Last year's conference brought
together hundreds of institutional and retail investors in an intimate format.

For more information or registration to present or attend, contact your Jesup
salesperson, Donald A. Wojnowski at dwojnowski@jesuplamont.com or Tammy Kraus
at tkraus@jesuplamont.com. You can also register online at
www.jesuplamontconferences.com.

About Jesup & Lamont, Inc.

Established in 1877, Jesup & Lamont, Inc. has an extensive history on Wall
Street, with its origins encompassing such successes as providing brokerage
services to Standard Oil and raising capital for the construction of
Rockefeller Center. Jesup & Lamont, through its two wholly owned brokerage
subsidiaries, offers full service broker-dealer and registered investment
advisory services through its approximately 150 retail brokers in over 20
locations including offices in New York, San Francisco, Boston, Boca Raton,
Chicago, Fort Lauderdale and Orlando. The Company's Jesup & Lamont Securities
Corporation subsidiary also publishes proprietary research on several
industries including Aerospace/Defense, Alternative Energy and Life
Sciences/Healthcare and offers comprehensive investment banking services.

Forward-Looking Statement Disclaimer

This press release contains "forward looking statements" within the meaning of
the Private Securities Litigation Reform Act of 1995. Such forward-looking
statements involve known and unknown risk, uncertainties or other factors
which may cause actual results, performance or achievements of the Company to
be materially different from any future results, performance or achievements
expressed or implied by such forward-looking statements. Factors that might
cause such a difference include, without limitation, fluctuations in the
volume of transactional services provided by the Company, competition with
respect to financial services commission rates, the effect of general economic
and market conditions, factors affecting the securities brokerage industry as
well as other risks and uncertainties detailed from time to time in the
Company's Securities and Exchange Commission filings. The Company undertakes
no obligation to revise or update any forward-looking statement.

SOURCE Jesup & Lamont, Inc.

Donald A. Wojnowski, President of Jesup & Lamont, Inc., +1-212-307-2660,
DWojnowski@Jesuplamont.com